There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

First-in-class drugs are therapies that utilize novel mechanisms of action, offering new approaches to challenging diseases. In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new ...

As the industry plunged into the holiday season in December, the last month of the year saw fewer merger and acquisition (M&A) deals compared to November. AbbVie took the top spot with its acquisition ...

Various PD-1 and PD-L1 checkpoint inhibitors have been approved by U.S. regulators including blockbuster drugs Keytruda, Imfinzi, and Opdivo to treat different types of cancer. But that hasn’t stopped ...